Harada-like syndrome post-Covishield vaccination: A rare adverse effect

Area of Science:

• Ophthalmology
• Immunology
• Vaccinology

Background:

• The Covishield vaccine, widely used in India, demonstrates approximately 80% efficacy.
• Serious side effects associated with the Covishield vaccine are currently under investigation.
• Vogt-Koyanagi-Harada (VKH) syndrome is a rare, idiopathic multisystem inflammatory disorder.

Observation:

• A 30-year-old female experienced sudden vision loss in both eyes, commencing 5 days prior to presentation and occurring 7 days post-Covishield vaccination.
• Clinical examination findings were highly suggestive of Vogt-Koyanagi-Harada (VKH) syndrome.
• The patient was treated with high-dose oral steroids.

Findings:

• An acute exacerbation of uveitis occurred 2 days after the second Covishield vaccine dose, despite ongoing corticosteroid treatment.
• This event suggests a potential direct correlation between the Covishield vaccine and the development of Harada-like syndrome.
• The temporal relationship and clinical presentation indicate a possible vaccine-induced immune response.

Implications:

• This case highlights a potential, albeit rare, serious adverse event following Covishield vaccination.
• Further research is warranted to elucidate the immunological mechanisms potentially linking VKH syndrome to the Covishield vaccine.
• Enhanced pharmacovigilance is crucial for monitoring and understanding rare side effects of widely administered vaccines.